Eli Perencevich is an Infectious Disease provider in Baltimore, Maryland. Dr. Perencevich is rated as an Elite provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Sepsis, Pneumonia, and Severe Acute Respiratory Syndrome (SARS).

Dr. Aaron M. Milstone is a professor of pediatrics at the Johns Hopkins University School of Medicine. He holds a joint appointments in Epidemiology and Health Policy and Management at the Bloomberg School of Public Health. A pediatric epidemiologist, Dr. Milstone specializes in treating infectious diseases in children. He serves as an associate hospital epidemiologist at The Johns Hopkins Hospital and the pediatric lead for infection prevention for the Johns Hopkins Health System. Dr. Milstone earned his medical degree from Yale University School of Medicine. He completed both a pediatrics residency and a research fellowship in pediatric infectious diseases at Children's Hospital of Philadelphia. He also completed a pediatric infectious diseases fellowship at Johns Hopkins. He holds a M.H.S. (Graduate Training Program in Clinical Investigation) from the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins University School of Medicine. Dr. Milstone joined the Johns Hopkins faculty in 2007. His research interests focus on antibiotic resistance and prevention of healthcare-associated infections. He had led numerous clinical trials including the Pediatric SCRUB Trial and TREAT PARENTS Trial testing strategies to prevent organism transmission and healthcare-associated infections. He is principal investigator of the BrighT STAR Collaborative, guiding hospitals nationwide to reduce over-testing as a strategy to reduce antibiotic use and resistance. Dr. Milstone is a fellow of the American Academy of Pediatrics, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society for Healthcare Epidemiology of America. His many other professional honors include the Pediatric Infectious Diseases Society’s 2014 Young Investigator Award, the inaugural 2013 Caroline B. Hall Clinical Innovation Award, and the Society for Healthcare Epidemiology of America 2018 Mentor Scholar Award, and 2023 Johns Hopkins Medicine Armstrong Award for Excellence in Quality & Safety. Dr. Milstone is rated as a Distinguished provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Sepsis, Methicillin-Resistant Staphylococcus Aureus (MRSA), Severe Acute Respiratory Syndrome (SARS), and Neonatal Sepsis.

Dr. Cosgrove is a Professor of Medicine in the Division of Infectious Disease (ID) at Johns Hopkins University School of Medicine and has a joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Research for the ID Fellowship Program and PI of the T32 training grant that supports ID fellow training. She serves as the Director of the Department of Antimicrobial Stewardship and an Associate Hospital Epidemiologist at The Johns Hopkins Hospital. Dr. Cosgrove’s research interests include the epidemiology and outcomes of antimicrobial resistance, the development of tools and programs to promote the rational use of antimicrobials, the prevention of hospital-acquired infections, and the epidemiology and management of S. aureus bacteremia. Early in her career, she recognized the critical need to study antimicrobial stewardship strategies and has led a series of outcomes studies over the past 20 years that have defined the practice of antimicrobial stewardship in the United States. Her recent research focuses on strategies for implementation of antimicrobial stewardship activities across all healthcare settings via a large, multi-center project including hospitals, long-term care facilities and ambulatory practices funded by the Agency for Healthcare Research and Quality, and approaches to improve how antibiotics are given via a randomized trial to compare intravenous and oral therapy for Gram negative bacteremia funded by PCORI. She is the PI of the Johns Hopkins Prevention Epicenter, a Centers for Disease Control and Prevention-funded program that integrates antimicrobial stewardship, healthcare epidemiology, human factors engineering, data science, and implementation science to address knowledge gaps and develop strategies to optimize patient safety by preventing transmission of pathogens and improving antibiotic use in diverse healthcare settings and patient populations. She is a past voting member of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria. She is a Past President of the Society for Healthcare Epidemiology’s Board of Directors. Dr. Cosgrove received her undergraduate degree from Columbia College, her medical degree from Baylor College of Medicine, and her master of science degree in epidemiology from Harvard School of Public Health. She completed her postgraduate training in internal medicine at The Johns Hopkins Hospital and underwent subsequent training in ID at Beth Israel Deaconess Medical Center. Dr. Cosgrove is rated as a Distinguished provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Sepsis, Methicillin-Resistant Staphylococcus Aureus (MRSA), Pneumonia, and Pseudomonas Stutzeri Infections.

Karen Carroll is an Infectious Disease provider in Baltimore, Maryland. Dr. Carroll is rated as a Distinguished provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Sepsis, Pneumonia, Meningitis, and Bone Marrow Aspiration. Dr. Carroll is currently accepting new patients.

Lisa Maragakis, M.D., M.P.H., FSHEA, FIDSA is a professor of medicine and epidemiology at Johns Hopkins University School of Medicine and the Johns Hopkins Bloomberg School of Public Health. Dr. Maragakis is the Senior Director of Infection Prevention, for The Johns Hopkins Health System and the Hospital Epidemiologist for The Johns Hopkins Hospital. In these roles, she is responsible for the conceptualization, planning, implementation, and development of the Johns Hopkins Health System's infection control and prevention program. Her research interests are the epidemiology, prevention and control of healthcare-acquired infections and antimicrobial-resistant gram-negative bacilli. Dr. Maragakis serves as the Executive Director of the Johns Hopkins Hospital Biocontainment Unit and as Incident Commander for the Johns Hopkins Medicine COVID-19 response. She also serves as the IDSA Co-Chair for the 2022 Update of the Compendium of Strategies to Prevent Healthcare-Associated Infections, and as Co-Chair of the Centers for Disease Control and Prevention's Healthcare Infection Control Practices Advisory Committee (HICPAC). Dr. Maragakis is rated as an Advanced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Ebola Virus Disease, Severe Acute Respiratory Syndrome (SARS), Viral Hemorrhagic Fever, and Bone Marrow Aspiration.

Dr. Bass attended Duke University for college and medical school, and received residency training in internal medicine and an MPH degree from the University of Pittsburgh. He completed a fellowship in general internal medicine at Johns Hopkins, and joined the Johns Hopkins faculty in 1989. His strongest research interests are in evidence-based medicine and assessment of the effectiveness, safety, and costs of medical and surgical management strategies. He has been the Director of the Johns Hopkins Evidence-based Practice Center since 2001. His teaching activities focus on medical student education at the interface between medicine and public health. He is the Director of the medical school's course on Foundations of Public Health, and Co-Director of the medical school's Scholarly Concentration in Public Health Research. He was the Director of the General Internal Medicine Fellowship at Johns Hopkins for 15 years. He served as the Editor of the Journal of General Internal Medicine for 5 years, and was the founding Editor-in-Chief of a journal dedicated to community-based participatory research called Progress in Community Health Partnerships. He has been the CEO of the Society of General Internal Medicine since 2017. He has published more than 250 peer-reviewed articles and over 50 evidence reports. He continues to have a clinical practice as a general internist. Dr. Bass is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Testicular Cancer, Varicose Veins, Type 2 Diabetes (T2D), Leydig Cell Testicular Tumor, and Orchiectomy.

Dr. Moon’s area of clinical expertise is infectious diseases. She earned her M.D. at the Ross University School of Medicine. Dr. Moon completed her residency at Allegheny General Hospital and performed a fellowship in infectious diseases at Penn State Milton S. Hershey Medical Center. Dr. Moon is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Hepatitis C, Hepatitis, Osteomyelitis, and HIV/AIDS.

Charles Bornmann is an Infectious Disease provider in Baltimore, Maryland. Dr. Bornmann is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Infective Endocarditis, Sepsis, Osteomyelitis, and Myelitis.

John Baddley is an Infectious Disease provider in Baltimore, Maryland. Dr. Baddley is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Cryptococcosis, Shingles, Sepsis, and Febrile Neutropenia.

Mary-claire Roghmann is an Infectious Disease provider in Baltimore, Maryland. Dr. Roghmann is rated as an Advanced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Sepsis, and Leg or Foot Amputation.

James Doub is an Infectious Disease provider in Baltimore, Maryland. Dr. Doub is rated as an Advanced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Infectious Arthritis, Methicillin-Resistant Staphylococcus Aureus (MRSA), Osteomyelitis, and Cellulitis. Dr. Doub is currently accepting new patients.

Manjari Joshi is an Infectious Disease provider in Baltimore, Maryland. Dr. Joshi is rated as an Advanced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Necrotizing Fasciitis and Methicillin-Resistant Staphylococcus Aureus (MRSA).

Shyamasundaran Kottilil is an Infectious Disease provider in Baltimore, Maryland. Dr. Kottilil is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Hepatitis B. Dr. Kottilil is currently accepting new patients.

Styliani Karanika is an Infectious Disease provider in Baltimore, Maryland. Dr. Karanika is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA) and Pseudomonas Stutzeri Infections.

William F. Wright, D.O., M.P.H, Assistant Professor of Medicine, completed medical training residency in internal medicine and adult infectious diseases fellowship at Pennylvania State University Medical School. He pursued further training in Clinical Pathology/Medical Microbiology at Yale University School of Medicine, New Haven (2009) and completed his Master in Public Health (2007) at Drexel University School of Public Health, Philadelphia. His research interests include fever of unknown origin (FUO), antimicrobial resistance and therapeutic discoveries, molecular mechanisms of resistance, and the impact of diagnostic clinical microbiology on the practice of infectious diseases. He currently serves as clinical director for the inpatient infectious diseases consult services and services for the management of outpatient parenteral antimicrobial therapy (OPAT) at Johns Hopkins Bayview Medical Center. His outpatient clinical practice focuses on general infectious diseases, infections in burn patients, infections in immunocompromised patients, and travel-related infections. He primarily sees patients at Johns Hopkins Greenspring Station, Johns Hopkins Bayview Outpatient offices, and also attends on the inpatient infectious disease consult service at the Johns Hopkins Bayview Medical Center and Johns Hopkins Hospital. Dr. Wright is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Osteomyelitis, Osteomyelitis in Children, Meningitis, and Endocarditis.

Kellen Knowles is a primary care provider, practicing in Cardiologist in Baltimore, Maryland. Dr. Knowles is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Endocarditis and Methicillin-Resistant Staphylococcus Aureus (MRSA).

Morgan Katz, M.D., MHS, is an Associate Professor of medicine at The Johns Hopkins University School of Medicine and the Director of Antimicrobial Stewardship at Johns Hopkins Bayview Hospital. Her area of clinical expertise is infectious diseases. Her research interests lie in infection control and antibiotic stewardship in long-term care facilities. She has focused her career on designing feasible interventions to reduce antimicrobial resistance and transmission of infection in the long-term care setting. She served as a member of the White House Nursing Home Commission to guide the Centers for Medicare and Medicaid in their response to Coronavirus in long-term care facilities, and has published widely on infection prevention and antibiotic stewardship in long-term care. Dr. Katz is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Lemierre Syndrome, Severe Acute Respiratory Syndrome (SARS), COVID-19, Osteomyelitis, and Thrombectomy.

Mamuka Machaidze is an Infectious Disease specialist and a Hospital Medicine provider in Baltimore, Maryland. Dr. Machaidze is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Osteomyelitis, Osteomyelitis in Children, Infectious Arthritis, and Pustules.

Dr. Michael Fingerhood is a professor of medicine and public health at the Johns Hopkins University. His areas of clinical expertise include addiction medicine and internal medicine. He earned his M.D. from the Albert Einstein College of Medicine of Yeshiva University. He completed his residency at Johns Hopkins. Dr. Fingerhood's research interests include substance use disorders, contingency management, hepatitis C and HIV. He is a member of several professional organizations, including the American Society of Addiction Medicine, the American Academy of HIV Medicine, The Society of General Internal Medicine and the American College of Physicians. Dr. Fingerhood is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Opioid Use Disorder, HIV/AIDS, Myelitis, and AIDS Dementia Complex.

James Ladd is a primary care provider, practicing in Infectious Disease in Baltimore, Maryland. Dr. Ladd is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Aspergillosis, Osteomyelitis, Osteomyelitis in Children, Infective Endocarditis, and Balloon Sinuplasty.